Additional studies concluded that AMPK agonists are effective in the treatment of cancer [15], [18], while other studies showed that the lipogenic enzyme fatty acid synthase (FASN) is regulated by energy intake and plays a crucial role in carcinogenesis [19]. This evidence concerns the gene FASN and cancer.